JPH10158290A - Retional glycoside and cosmetic obtained by formulating the same glycoside - Google Patents

Retional glycoside and cosmetic obtained by formulating the same glycoside

Info

Publication number
JPH10158290A
JPH10158290A JP8329103A JP32910396A JPH10158290A JP H10158290 A JPH10158290 A JP H10158290A JP 8329103 A JP8329103 A JP 8329103A JP 32910396 A JP32910396 A JP 32910396A JP H10158290 A JPH10158290 A JP H10158290A
Authority
JP
Japan
Prior art keywords
skin
glycoside
retinol
cosmetic
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP8329103A
Other languages
Japanese (ja)
Inventor
Yoichi Watanabe
洋一 渡辺
Junichi Inata
淳一 生稲
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nisshin Oil Mills Ltd
Original Assignee
Nisshin Oil Mills Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nisshin Oil Mills Ltd filed Critical Nisshin Oil Mills Ltd
Priority to JP8329103A priority Critical patent/JPH10158290A/en
Publication of JPH10158290A publication Critical patent/JPH10158290A/en
Pending legal-status Critical Current

Links

Abstract

PROBLEM TO BE SOLVED: To obtain the subject new glycoside comprising a specific retinol glycoside and useful as a skin cosmetic, capable of imparting tenseness and gloss to skin and remarkably improved in preventing and improving effect on formula of wrinkles and slackness caused together with aging of skin. SOLUTION: This new retinal glycoside is represented by the formula [R is glucosyl residue such as glucose or galactose; (n) is an integer of 1-3] and useful as a component for skin cosmetic, etc., capable of imparting tenseness and gloss to skin and remarkably improved in preventing and improving effect on formation of wrinkles and slackness caused together with aging of skin. The compound is obtained by adding retinol, glucose pentaacetate and anhydrous iron (III) chloride to dichloromethane, mixing these components overnight at ambient temperature, cleaning dichloromethane solution of the product with a saturated aqueous solution of sodium hydrogencarbonate, washing the solution with water, adding sodium methoxide and ethanol to the concentrate, refluxing the solution for 6hr and concentrating the solution and purifying the concentrate with column chromatography.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は皮膚の老化を予防お
よび改善する効果を著しく向上させた化粧料に関する。
さらに詳しくは、皮膚の老化に伴って生じるシワ、荒れ
肌および乾燥肌の改善効果に優れた皮膚化粧料に関す
る。
[0001] The present invention relates to a cosmetic composition having significantly improved effects of preventing and improving skin aging.
More specifically, the present invention relates to a skin cosmetic excellent in the effect of improving wrinkles, rough and dry skin caused by aging of the skin.

【0002】[0002]

【従来の技術】皮膚は、細胞が直接外気にさらされてい
る特殊な環境下にあり、内臓器の老化現象と比較してよ
り外的要因による影響を受けやすい状態にある。皮膚の
老化には加齢による生物学的老化と、外部要因の中で最
も影響の大きい太陽光による光老化があり、両者が複合
し進行すると考えられている。一般的に、皮膚の老化現
象の目安となる肌のシワやたるみを形成する主な原因と
して、皮膚の真皮組織における構成成分の質的および量
的変化が大きく影響を及ぼすといわれている。つまり、
皮膚の強さ、柔軟性、弾力性をきめているのは、主にコ
ラーゲン繊維とエラスチン繊維など真皮組織に存在する
繊維性蛋白成分であり、これらが種々の外的または内的
要因により蛋白質変性をおこし、それに伴い弾力性が低
下して結果的にシワやたるみが生じると考えられてい
る。このような老化現象に対し、皮膚にはりやツヤを与
え、シワやたるみの発生を防止したり、改善したりす
る、いわゆる肌の老化防止、シワ改善を目的とする化粧
料には種々のタイプの製品が提案されている。
2. Description of the Related Art Skin is in a special environment where cells are directly exposed to the outside air, and is more susceptible to external factors than the aging phenomenon of internal organs. Skin aging includes biological aging due to aging and photoaging due to sunlight, which is the most influential of external factors, and it is thought that both proceed in combination. In general, it is said that qualitative and quantitative changes in components in the dermis tissue of the skin have a major effect as a main cause of formation of wrinkles and sagging of the skin, which is a measure of skin aging. That is,
The strength, flexibility and elasticity of the skin are determined mainly by fibrous protein components such as collagen fibers and elastin fibers, which are present in the dermal tissue, and these are protein denatured by various external or internal factors. It is thought that the elasticity is reduced and wrinkles and sagging are caused as a result. Various types of cosmetics are provided for the purpose of preventing skin aging and improving wrinkles by giving the skin shine and gloss to such aging phenomena and preventing or improving the occurrence of wrinkles and sagging. Products have been proposed.

【0003】代表的なものとして、多価アルコール類
(グリセリン、プロピレングリコール、ソルビトール
等)、天然保湿因子(Natural Moisturizing Factor :
アミノ酸、乳酸塩、ピロリドンカルボン酸ソーダ、尿素
等) 、酸性ムコ多糖(ヒアルロン酸、コンドロイチン硫
酸等)、植物性多糖(ペクチン、カラギーナン、トレハ
ロース等)、動物性多糖(キチン誘導体、キトサン誘導
体等)、繊維状蛋白質(コラーゲン、エラスチン、プラ
センタ等)、細胞間脂質(リン脂質、スフィンゴ脂質、
ステロール等)、皮脂類似物質(オリーブ油、ホホバ
油、スクワラン等)等の保湿成分を配合した化粧料があ
る。これらは乾燥という外的要因に対する防御として表
皮角層の保湿機能を維持、亢進するために用いられるも
のであり、表皮に生じるシワを予防、改善する目的で使
用される。なお、真皮組織に生じたシワについては、予
防、改善効果は一般的に認められていない。
[0003] As typical examples, polyhydric alcohols (glycerin, propylene glycol, sorbitol, etc.), natural moisturizing factors:
Amino acids, lactates, sodium pyrrolidone carboxylate, urea), acidic mucopolysaccharides (hyaluronic acid, chondroitin sulfate, etc.), vegetable polysaccharides (pectin, carrageenan, trehalose, etc.), animal polysaccharides (chitin derivatives, chitosan derivatives, etc.), Fibrous protein (collagen, elastin, placenta, etc.), intercellular lipid (phospholipid, sphingolipid,
There are cosmetics containing moisturizing ingredients such as sterols and sebum-like substances (olive oil, jojoba oil, squalane, etc.). These are used to maintain and enhance the moisturizing function of the horny layer of the epidermis as protection against an external factor of drying, and are used for the purpose of preventing and improving wrinkles generated in the epidermis. The effects of preventing and improving wrinkles generated in the dermal tissue are not generally recognized.

【0004】皮膚の老化に関わる最も大きな外的要因で
ある紫外線に対しては、種々の防御剤が開発されてお
り、光化学的に吸収する吸収剤や物理的に散乱、反射す
る散乱剤などを配合した化粧料が用いられている。紫外
線吸収剤を分類するとベンゾフェノン系、パラアミノ安
息香酸系、メトキシ桂皮酸系、サリチル酸系などに分け
られるが、刺激性や感作性等の問題があることがあり、
安全性の高い吸収剤の開発が望まれている。また、これ
らの紫外線吸収剤はほとんどが中波長紫外線(UVB)
領域に最大吸収波長があり、更に優れた長波長紫外線
(UVA)吸収剤の開発が必要である。紫外線散乱剤と
しては、酸化チタン、酸化亜鉛等の無機顔料があり、安
全性も高く、広い領域の紫外線に対応できるが、有効量
を配合すると隠蔽作用により素肌感が失われ、処方設計
上で制約をうける欠点がある。
[0004] Various protective agents have been developed for ultraviolet rays, which is the largest external factor relating to skin aging, and photochemically absorbing absorbers and scattering agents that physically scatter and reflect are used. Blended cosmetics are used. UV absorbers are classified into benzophenones, paraaminobenzoic acids, methoxycinnamic acids, salicylic acids, etc., but may have problems such as irritation and sensitization.
The development of highly safe absorbents is desired. Most of these UV absorbers are medium wavelength ultraviolet (UVB)
There is a need for the development of better long wavelength ultraviolet (UVA) absorbers, where the region has a maximum absorption wavelength. As an ultraviolet scattering agent, there are inorganic pigments such as titanium oxide and zinc oxide, which are highly safe and can cope with a wide range of ultraviolet rays. There are disadvantages subject to restrictions.

【0005】皮膚の老化に及ぼす重要な内的要因として
は、真皮を構成するコラーゲン、エラスチンなどの繊維
状蛋白質を産生する繊維芽細胞の活性低下が挙げられ
る。繊維芽細胞の活性が低下することにより、真皮中の
コラーゲン、エラスチン量が減少し、皮膚が薄くなるこ
とにより弾力性が欠けシワが生じやすくなるためと考え
られる。このような活性が低下した細胞に対し、老化す
る前の活性に近づける目的で用いられる物質が細胞賦活
剤であり、老化防止化粧料の有効成分として重要な位置
を占めている。細胞賦活剤には、ビタミン類、動植物抽
出物、α−ヒドロキシ酸等があるが、いずれもシワ改善
化粧料として十分な機能を果たす有効な成分は見出され
ていないのが現状である。例えば、グリコール酸、乳
酸、リンゴ酸、クエン酸等のα−ヒドロキシ酸は、繊維
芽細胞を刺激したり、細胞間基質の生合成を促進し、真
皮のシワを改善するという報告もあるが、有効濃度は6
〜12%と高く、配合処方上の制約から、より低濃度で
使用目的が達せられるような更に有効性の高いα−ヒド
ロキシ酸の開発が期待されている。また、皮脂腺萎縮作
用を有し、アクネの治療薬として開発されたレチノイン
酸は、コラーゲン新生を促進し有意にシワを改善するこ
とが報告されており、米国では老化防止の化粧料に使用
されている。しかし、レチノイン酸には、種々の副作用
や、奇形性等の安全性の問題が指摘されており、日本で
化粧料に配合することは困難である。以上のように、真
皮レベルでシワを改善する方策としては、繊維芽細胞を
活性化させる細胞賦活剤の利用が期待されているが、有
効性、安全性の面で十分な機能を果たす成分が見出され
ていないのが現状である。
[0005] An important internal factor affecting skin aging is a decrease in the activity of fibroblasts that produce fibrous proteins such as collagen and elastin that constitute the dermis. It is considered that the decrease in the activity of fibroblasts leads to a decrease in the amount of collagen and elastin in the dermis, and the thinning of the skin results in a lack of elasticity and easy wrinkling. Substances used for the purpose of bringing the activity of such cells with reduced activity close to the activity before aging are cell activators and occupy an important position as an active ingredient of anti-aging cosmetics. Cell activators include vitamins, plant and animal extracts, α-hydroxy acids, and the like. However, at present, no effective component has been found that performs a sufficient function as a wrinkle improving cosmetic. For example, there are reports that α-hydroxy acids such as glycolic acid, lactic acid, malic acid and citric acid stimulate fibroblasts, promote biosynthesis of intercellular matrix, and improve dermal wrinkles, Effective concentration is 6
Due to the restrictions on the formulation, it is expected to develop α-hydroxy acids having higher efficacies so that the intended use can be achieved at lower concentrations. In addition, it has been reported that retinoic acid, which has sebaceous gland atrophy and has been developed as a therapeutic agent for acne, promotes collagen renewal and significantly improves wrinkles, and is used in the United States for anti-aging cosmetics. I have. However, retinoic acid has been pointed out with various side effects and safety problems such as malformation, and it is difficult to incorporate it into cosmetics in Japan. As described above, as a measure to improve wrinkles at the dermis level, the use of a cell activator that activates fibroblasts is expected, but there are components that function sufficiently in terms of efficacy and safety. At present it has not been found.

【0006】[0006]

【発明が解決しようとする課題】本発明の目的は、肌に
対してはり、ツヤを与え、皮膚の老化に伴って生じるシ
ワやたるみの形成を予防し、改善する効果を著しく向上
させた化粧料を提供することにある。
SUMMARY OF THE INVENTION It is an object of the present invention to provide a cosmetic which has a markedly improved effect of giving skin a shine and luster and preventing and improving the formation of wrinkles and sagging caused by aging of the skin. To provide a fee.

【0007】[0007]

【課題を解決するための手段】前記目的を達成するた
め、本発明者らは鋭意検討した結果、特定のレチノール
配糖体に顕著な細胞賦活作用を有すること、及びそれを
配合した化粧料に適用することにより、シワやたるみの
形成を予防し、改善できることを見出し、本発明を完成
するに至った。すなわち、本発明の要旨は下記の構造式
(1)
Means for Solving the Problems In order to achieve the above object, the present inventors have made intensive studies and found that a specific retinol glycoside has a remarkable cell activating effect, and that a cosmetic containing the same has a retinol glycoside. It has been found that the application can prevent and improve the formation of wrinkles and sagging, and have completed the present invention. That is, the gist of the present invention is represented by the following structural formula (1)

【0008】[0008]

【化3】 Embedded image

【0009】(式(1)中、Rはグルコース、ガラクト
ースからなる群より選ばれる1種または2種以上のグリ
コシル残基を表し、nは1〜3の整数値のいずれかを表
す)で示されるレチノール配糖体及びそれを配合してな
る化粧料であり、さらには前記レチノール配糖体ととも
に保湿剤、より好ましくは多価アルコール類および/ま
たは天然保湿因子、酸性ムコ多糖、植物性多糖、動物性
多糖、繊維状蛋白質、細胞間脂質、皮脂類似物質等を併
用して配合してなる化粧料である。以下に本発明を詳細
に説明する。まず、本発明において必須成分として用い
るレチノール配糖体を一般化学構造式で表現すれば、前
記の一般式(1)で示される。すなわち、本発明に係わ
るレチノール配糖体は、炭化水素としてβ−シクロヘキ
シニル環を、側鎖にはイソプレンを有し、末端がヒドロ
キシル基であるレチノイド(レチノール)部分と、その
ヒドロキシル基にグルコース、ガラクトースからなる群
から選ばれる1種または2種以上の糖残基が1〜3分子
結合している糖部分とから構成されるものである。
(In the formula (1), R represents one or more glycosyl residues selected from the group consisting of glucose and galactose, and n represents any one of integers from 1 to 3.) Retinol glycosides and cosmetics comprising the same, further comprising a humectant together with the retinol glycoside, more preferably a polyhydric alcohol and / or a natural moisturizing factor, an acidic mucopolysaccharide, a vegetable polysaccharide, It is a cosmetic that is formulated by combining animal polysaccharides, fibrous proteins, intercellular lipids, sebum-like substances, and the like. Hereinafter, the present invention will be described in detail. First, when the retinol glycoside used as an essential component in the present invention is represented by a general chemical structural formula, it is represented by the general formula (1). That is, the retinol glycoside according to the present invention has a β-cyclohexynyl ring as a hydrocarbon, a retinoid (retinol) moiety having a side chain having isoprene and a terminal hydroxyl group, and glucose at the hydroxyl group. One or two or more sugar residues selected from the group consisting of galactose are composed of a sugar moiety having 1 to 3 molecules bonded thereto.

【0010】本発明で対象とするレチノール配糖体は、
好ましくは前記一般式(1)において糖残基がモノグリ
コシド残基および/またはジグリコシド残基であるグリ
コシドレチノールであり、さらにより好ましくは糖残基
としてグルコースを主成分とするものである。かかるレ
チノール配糖体は、レチノールと糖類とを混合、加熱し
てエーテル化するような化学的合成法によって調製して
もよいが、製品の色、臭い等の品質面を考慮すると酵素
的に合成する方法を用いる方が望ましい。酵素として
は、グリコシダーゼ等の配糖体加水分解酵素を用いるこ
とが可能である。
The retinol glycoside targeted by the present invention is:
Preferably, the sugar residue in the formula (1) is a glycoside retinol, which is a monoglycoside residue and / or a diglycoside residue, and still more preferably, the sugar residue is mainly composed of glucose. Such a retinol glycoside may be prepared by a chemical synthesis method in which retinol and a saccharide are mixed, heated and etherified, but are enzymatically synthesized in consideration of the quality of the product, such as color and odor. It is more preferable to use the method of As the enzyme, a glycoside hydrolase such as glycosidase can be used.

【0011】次に、本発明に係わるレチノール配糖体の
特徴的な性状である、細胞賦活作用を測定する方法を以
下に示す。細胞賦活効果は、細胞毒性評価法の一つであ
るMTT(3−(4,5−ジメチル−2−チアゾニル)
−2,5−ジフェニルテトラゾリウムブロマイド)還元
法を応用して評価する。すなわちヒト線維芽細胞にMT
Tを添加し生成するホルマザン量を吸光度により測定す
る。MTTは生細胞に取り込まれると、ミトコンドリア
に存在するNADHにより還元的解裂を受け、ブルーホ
ルマザンに変換される。従って、このMTT還元法によ
り得られるホルマザン量はNADH量に相当し、ミトコ
ンドリアの代謝活性すなわち細胞のエネルギー代謝活性
を反映していると考える事が出来る。本発明に係わるレ
チノール配糖体は、微小濃度でも高いホルマザン生成量
を示し、細胞賦活作用をもつ有効成分として極めて高い
活性を有するものである。
Next, a method for measuring a cell activating effect, which is a characteristic property of the retinol glycoside according to the present invention, will be described below. The cell activating effect is measured by MTT (3- (4,5-dimethyl-2-thiazonyl), which is one of the cytotoxicity evaluation methods.
(2,5-diphenyltetrazolium bromide) reduction method. That is, MT is added to human fibroblasts.
The amount of formazan formed by adding T is measured by absorbance. When MTT is taken into living cells, it undergoes reductive cleavage by NADH present in mitochondria and is converted to blue formazan. Therefore, the amount of formazan obtained by this MTT reduction method corresponds to the amount of NADH and can be considered to reflect the metabolic activity of mitochondria, that is, the energy metabolic activity of cells. The retinol glycoside according to the present invention exhibits a high formazan production amount even at a minute concentration, and has extremely high activity as an active ingredient having a cell activating action.

【0012】このため、前述した本発明に係わるレチノ
ール配糖体を化粧品、トイレタリー製品、医薬部外品等
の種々の皮膚適用製品に利用することは、肌の老化を防
止するとともに皮膚を活性化し肌の老化を改善するうえ
で極めて有用であると考えられる。この考えをもとにな
された本発明の趣旨は、前記構造式(1)で示されるレ
チノール配糖体を必須成分として配合してなることを特
徴とする化粧料に関するものである。本発明の化粧料の
種類としては、特に限定されるものではないが、とりわ
け皮膚に対して使用する公知の各種化粧品を対象とする
ことが望ましく、例えばコールドクリーム、バニシング
クリーム、エモリエントクリーム、サンスクリーンクリ
ーム等の各種クリーム、乳液、化粧水、ファンデーショ
ン、洗顔料、美容液、パック剤等があげられる。トイレ
タリー製品についても同様に制限はないが、石鹸、入浴
剤等を好適に例示できる。かかるレチノール配糖体の化
粧料への配合量は、0.001重量%以上であり、配合
の上限は特に限定しないが、極端に多量に配合した場合
には本発明の効果を損なうわけではないものの、結晶の
析出等により化粧料としての品質が保てなくなる場合が
ある。好ましくは10重量%以下である。
For this reason, the use of the above-mentioned retinol glycoside according to the present invention in various skin-applied products such as cosmetics, toiletry products, and quasi-drugs prevents skin aging and activates the skin. It is considered to be extremely useful in improving skin aging. The gist of the present invention based on this idea relates to a cosmetic comprising the retinol glycoside represented by the structural formula (1) as an essential component. The type of the cosmetic of the present invention is not particularly limited, but it is particularly desirable to target various known cosmetics used for the skin, such as cold cream, burnishing cream, emollient cream, and sunscreen. Examples include various creams such as creams, milky lotions, lotions, foundations, facial cleansers, serums, packs, and the like. Although there is no limitation on toiletry products as well, soaps, bath additives and the like can be preferably exemplified. The amount of such a retinol glycoside blended in the cosmetic is 0.001% by weight or more, and the upper limit of the blending is not particularly limited. However, when blended in an extremely large amount, the effect of the present invention is not impaired. However, the quality as a cosmetic may not be maintained due to precipitation of crystals and the like. It is preferably at most 10% by weight.

【0013】本発明の化粧料は、前記レチノール配糖体
と他の公知の成分とを用いて、常法により調製すること
ができる。すなわち公知の油性成分、界面活性剤、保湿
剤、増粘剤、防腐剤、顔料、粉体、pH調製剤、抗酸化
剤、紫外線吸収剤、香料、色素、精製水等を適宜に配合
すればよい。なお、本発明の化粧料においては、本発明
に係わるレチノール配糖体と保湿剤とを併用して配合す
ることにより、本発明の効果すなわちシワやたるみの形
成を防ぎ、皮膚にハリとツヤを付与する効果がより一層
顕著に発揮される。かかる保湿剤としては公知の化粧料
用原料である、多価アルコール類(グリセリン、プロピ
レングリコール、ソルビトール等)、天然保湿因子(Na
tural Moisturizing Factor: アミノ酸、乳酸塩、ピロ
リドンカルボン酸ソーダ、尿素等) 、酸性ムコ多糖(ヒ
アルロン酸、コンドロイチン硫酸等)、植物性多糖(ペ
クチン、カラギーナン、トレハロース等)、動物性多糖
(キチン誘導体、キトサン誘導体等)、繊維状蛋白質
(コラーゲン、エラスチン、プラセンタ等)、細胞間脂
質(リン脂質、スフィンゴ脂質、ステロール等)、皮脂
類似物質(オリーブ油、ホホバ油、スクワラン等)等が
好ましい。これらの保湿剤は単独でもまたは2種以上を
組み合わせても使用できる。レチノール配糖体と保湿剤
の併用割合は、本発明に係わるレチノール配糖体/保湿
剤=1/100〜100/1(重量比)がよい。
The cosmetic of the present invention can be prepared by a conventional method using the above-mentioned retinol glycoside and other known components. That is, if known oil components, surfactants, humectants, thickeners, preservatives, pigments, powders, pH adjusters, antioxidants, ultraviolet absorbers, fragrances, dyes, purified water, etc. are appropriately blended. Good. In the cosmetic of the present invention, by combining the retinol glycoside according to the present invention with the humectant, the effects of the present invention, i.e., the formation of wrinkles and sagging are prevented, and the skin becomes firm and shiny. The effect to be imparted is more remarkably exhibited. As such humectants, known cosmetic raw materials such as polyhydric alcohols (glycerin, propylene glycol, sorbitol, etc.), natural moisturizing factors (Na
tural Moisturizing Factor: amino acids, lactates, sodium pyrrolidonecarboxylate, urea, etc., acidic mucopolysaccharides (hyaluronic acid, chondroitin sulfate, etc.), vegetable polysaccharides (pectin, carrageenan, trehalose, etc.), animal polysaccharides (chitin derivatives, chitosan) Derivatives, etc., fibrous proteins (collagen, elastin, placenta, etc.), intercellular lipids (phospholipids, sphingolipids, sterols, etc.), sebum analogues (olive oil, jojoba oil, squalane, etc.) and the like are preferred. These humectants can be used alone or in combination of two or more. The combination ratio of the retinol glycoside and the humectant is preferably the retinol glycoside / humectant according to the present invention = 1/100 to 100/1 (weight ratio).

【0014】[0014]

【実施例】以下に参考例および実施例を示して本発明を
具体的に説明する。 製造例1 ジクロロメタン100mlにレチノール(シグマ(株)
製)5.8g,グルコースペンタアセテート(シグマ
(株)製)8.0gおよび無水塩化鉄(III)3.3
gを加える。室温で一晩かき混ぜ、ジクロロメタン溶液
を飽和炭化水素ナトリウム水溶液で洗浄した。さらにこ
れを水洗し、濃縮物にナトリウムメトキサイド18gと
エタノール100mlを加え、6時間還流した後、濃縮
した。濃縮物を水洗し、乾燥後、カラムクロマトグラフ
ィーにより精製レチノールグルコシド2gを得た。
EXAMPLES The present invention will be specifically described below with reference to Reference Examples and Examples. Production Example 1 Retinol (Sigma Co., Ltd.) in 100 ml of dichloromethane
5.8 g), 8.0 g of glucose pentaacetate (manufactured by Sigma) and 3.3 g of anhydrous iron (III) chloride.
Add g. Stir at room temperature overnight and wash the dichloromethane solution with saturated aqueous sodium hydrocarbon solution. This was further washed with water, and the concentrate was added with 18 g of sodium methoxide and 100 ml of ethanol, refluxed for 6 hours, and then concentrated. The concentrate was washed with water and dried, and then 2 g of purified retinol glucoside was obtained by column chromatography.

【0015】製造例2 ジクロロメタン100mlにレチノール(シグマ(株)
製)5.8g、ガラクトースペンタアセテート(シグマ
(株)製)8.0gおよび無水塩化鉄(III)3.3
gを加える。以下、製造例1と同様に行い、精製レチノ
ールガラクトシド2gを得た。
Production Example 2 Retinol (Sigma Co., Ltd.) was added to 100 ml of dichloromethane.
5.8 g), 8.0 g of galactose pentaacetate (manufactured by Sigma) and 3.3 g of anhydrous iron (III) chloride.
Add g. Hereinafter, the same procedure as in Production Example 1 was performed to obtain 2 g of purified retinol galactoside.

【0016】実施例1(クリーム) 表1に示す処方及び、下記の製造方法によりクリームを
調製した。また比較のためのクリームを同様に調製し、
両クリームの性状を評価した。その結果を表2に示す。
本発明のクリームは肌に対してはりとツヤを与える効果
が大きく、シワやたるみの形成を防止する効果が認めら
れた。
Example 1 (Cream) A cream was prepared according to the formulation shown in Table 1 and the following production method. Also prepare a cream for comparison in the same way,
The properties of both creams were evaluated. Table 2 shows the results.
The cream of the present invention has a large effect of giving a skin a shine and luster, and has an effect of preventing the formation of wrinkles and sagging.

【0017】[0017]

【表1】 ※1 製造例1で得た精製レチノールグルコシド ※2 製造例2で得た精製レチノールガラクトシド[Table 1] * 1 Purified retinol glucoside obtained in Production Example 1 * 2 Purified retinol galactoside obtained in Production Example 2

【0018】〔製造方法〕 (1) 〜(4) 、(7) 、(8) および(10)を加熱しながら
混合し、70〜80℃に保つ。 (12)に(5) 、(6) 、(9) および(11)を加えて加熱し
ながら混合し、70〜80℃に保つ。 の混合物にの混合物を徐々に加えながら攪拌
し、均一に乳化する。 を水浴に置き、室温になるまで攪拌を続けてクリ
ームを得る。
[Manufacturing method] (1) to (4), (7), (8) and (10) are mixed while heating and maintained at 70 to 80 ° C. (5), (6), (9) and (11) are added to (12), mixed while heating, and kept at 70 to 80 ° C. Stir while gradually adding the mixture to the above mixture, and uniformly emulsify. In a water bath and continue to stir to room temperature to obtain a cream.

【0019】〔評価方法〕20〜50代の女性10名を
パネルとし、毎日、朝夕の洗顔後2回、1か月間にわた
って、本発明クリーム及び、比較クリームの各適量を顔
面に塗布した。各クリームの評価は以下の基準によっ
た。 判 定 内 容 ────────────────────────────────── ○(効果が認められた) : 肌にはり、つやが付与され、 シワ、たるみが改善された。 △(効果がやや認められた) : 肌にはり、つやがやや付与され、 シワ、たるみが改善された。 ×(効果が認められなかった) : 使用前と変わらない
[Evaluation Method] An appropriate amount of each of the cream of the present invention and the comparative cream was applied to the face twice a day after washing the face in the morning and evening for 10 months, using 10 women in their 20s to 50s as panels. The evaluation of each cream was based on the following criteria. Judgment contents ────────────────────────────────── ○ (effect was recognized): Affix to skin , Gloss is given, wrinkles and sagging are improved. △ (Effect was recognized slightly): Slightly applied to the skin and gloss, wrinkles and sagging were improved. × (No effect was observed): Same as before use

【0020】[0020]

【表2】 [Table 2]

【0021】実施例2(乳液) 表3に示す処方及び、下記の製造方法により乳液を調製
した。また比較のための乳液を同様に調製し、両乳液の
性状を評価した(評価方法および基準は実施例1と同
じ)。その結果を表4に示す。本発明の乳液は肌に対し
てはりとツヤを与える効果が大きく、シワやたるみの形
成を防止する効果が認められた。
Example 2 (Emulsion) An emulsion was prepared according to the formulation shown in Table 3 and the following production method. In addition, an emulsion for comparison was prepared in the same manner, and the properties of both emulsions were evaluated (the evaluation method and criteria were the same as in Example 1). Table 4 shows the results. The emulsion of the present invention has a great effect of giving a shine and gloss to the skin, and an effect of preventing the formation of wrinkles and sagging was recognized.

【0022】[0022]

【表3】 ※1 製造例1で得た精製レチノールグルコシド ※2 製造例2で得た精製レチノールガラクトシド[Table 3] * 1 Purified retinol glucoside obtained in Production Example 1 * 2 Purified retinol galactoside obtained in Production Example 2

【0023】〔製造方法〕 (1) 〜(3) 、(6) 、(7) および(9) を加熱しながら
混合し、70〜80℃に保つ。 (11)に(4) 、(5) 、(8) および(10)を加えて加熱し
ながら混合し、70〜80℃に保つ。 の混合物にの混合物を徐々に加えながら攪拌
し、均一に乳化する。 を水浴に置き、室温になるまで攪拌を続けて乳液
を得る。
[Manufacturing method] (1) to (3), (6), (7) and (9) are mixed while heating, and kept at 70 to 80 ° C. (4), (5), (8) and (10) are added to (11), mixed while heating, and maintained at 70 to 80 ° C. Stir while gradually adding the mixture to the above mixture, and uniformly emulsify. In a water bath and continue stirring until it reaches room temperature to obtain an emulsion.

【0024】[0024]

【表4】 注)評価基準は実施例1と同じ。[Table 4] Note) Evaluation criteria are the same as in Example 1.

【0025】実施例3(化粧水) 表5に示す処方で化粧水を調製し、実施例1と同様の方
法で評価したところ、本発明品(3−1〜3−2)はい
ずれも肌に対してはりとツヤを与える効果が大きく、特
に3−2(ピロリドンカルボン酸ソーダとレチノールグ
ルコシドとの併用)ではその効果が顕著であった(表6
参照)。このことから本発明品では、皮膚のシワやたる
みの形成を防ぐ効果が認められることが明らかになっ
た。
Example 3 (Lotion) A lotion was prepared according to the formulation shown in Table 5 and evaluated in the same manner as in Example 1. As a result, the products of the present invention (3-1 to 3-2) were all skin In particular, the effect of 3-2 (combination of sodium pyrrolidonecarboxylate and retinol glucoside) was remarkable (Table 6).
reference). From this, it was clarified that the product of the present invention has an effect of preventing the formation of skin wrinkles and sagging.

【0026】[0026]

【表5】 ※ 製造例1で得た精製レチノールグルコシド[Table 5] * Purified retinol glucoside obtained in Production Example 1

【0027】[0027]

【表6】 注)評価基準は実施例1と同じ。[Table 6] Note) Evaluation criteria are the same as in Example 1.

【0028】実施例4(美容液) 表7に示す処方で美容液を調製し、実施例1と同様の方
法で評価したところ、本発明品(4−1〜4−3)はい
ずれも肌に対してはりとツヤを与える効果が大きく、特
に4−2および4−3(ヒアルロン酸とレチノールグル
コシドとの併用)ではその効果が顕著であった(表8参
照)。このことから本発明品では、皮膚のシワやたるみ
の形成を防ぐ効果が認められることが明らかになった。
Example 4 (Essence) A serum was prepared according to the formulation shown in Table 7, and evaluated in the same manner as in Example 1. The products of the present invention (4-1 to 4-3) were all skin 4-2 and 4-3 (in combination of hyaluronic acid and retinol glucoside) showed a remarkable effect (see Table 8). From this, it was clarified that the product of the present invention has an effect of preventing the formation of skin wrinkles and sagging.

【0029】[0029]

【表7】 ※ 製造例1で得た精製レチノールグルコシド[Table 7] * Purified retinol glucoside obtained in Production Example 1

【0030】[0030]

【表8】 注)評価基準は実施例1と同じ。[Table 8] Note) Evaluation criteria are the same as in Example 1.

【0031】[0031]

【発明の効果】本発明によれば、細胞賦活作用を有する
前記構造式(1)で示されるレチノール配糖体およびそ
れを配合してなる化粧料が提供される。本化粧料は肌に
はりやツヤを与え、皮膚のシワやたるみの形成を防止し
さらに改善する効果を奏する。また該効果は、前記化粧
料に保湿剤を併用することによりさらに顕著に発現され
る。
According to the present invention, there is provided a retinol glycoside represented by the structural formula (1) having a cell activating effect and a cosmetic comprising the same. The present cosmetic has an effect of giving a skin a luster and gloss, preventing the formation of wrinkles and sagging of the skin, and further improving it. The effect is further remarkably exhibited by using a humectant in combination with the cosmetic.

Claims (5)

【特許請求の範囲】[Claims] 【請求項1】 下記一般式(1)で示されるレチノール
配糖体。 【化1】 (式(1)中、Rはグルコース、ガラクトースからなる
群より選ばれる1種または2種以上のグルコシル残基を
表し、nは1〜3の整数値のいずれかを表す)
1. A retinol glycoside represented by the following general formula (1). Embedded image (In the formula (1), R represents one or more glucosyl residues selected from the group consisting of glucose and galactose, and n represents any one of integers from 1 to 3.)
【請求項2】 下記一般式(1)で示されるレチノール
配糖体を含有することを特徴とする化粧料。 【化2】 (式(1)中、Rはグルコース、ガラクトースからなる
群より選ばれる1種または2種以上のグルコシル残基を
表し、nは1〜3の整数値のいずれかを表す)
2. A cosmetic comprising a retinol glycoside represented by the following general formula (1). Embedded image (In the formula (1), R represents one or more glucosyl residues selected from the group consisting of glucose and galactose, and n represents any one of integers from 1 to 3.)
【請求項3】 化粧料がさらに保湿剤を含有してなる請
求項2記載の化粧料。
3. The cosmetic according to claim 2, wherein the cosmetic further comprises a humectant.
【請求項4】 保湿剤が、多価アルコール類、天然保湿
因子、酸性ムコ多糖、植物性多糖、動物性多糖、繊維状
蛋白質、細胞間脂質、皮脂類似物質等である請求項2お
よび請求項3に記載の化粧料。
4. The method according to claim 2, wherein the humectant is a polyhydric alcohol, a natural humectant, an acidic mucopolysaccharide, a vegetable polysaccharide, an animal polysaccharide, a fibrous protein, an intercellular lipid, a sebum-like substance, or the like. 3. The cosmetic according to 3.
【請求項5】 保湿剤が、グリセリン、ピロリドンカル
ボン酸ソーダ、ヒアルロン酸、トレハロース、キチン誘
導体、コラーゲン、リン脂質、スフィンゴ脂質、ホホバ
油の1種または2種以上である請求項2および請求項3
に記載の化粧料。
5. The humectant is one or more of glycerin, sodium pyrrolidonecarboxylate, hyaluronic acid, trehalose, chitin derivative, collagen, phospholipid, sphingolipid, and jojoba oil.
The cosmetic according to any one of the above.
JP8329103A 1996-11-25 1996-11-25 Retional glycoside and cosmetic obtained by formulating the same glycoside Pending JPH10158290A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP8329103A JPH10158290A (en) 1996-11-25 1996-11-25 Retional glycoside and cosmetic obtained by formulating the same glycoside

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8329103A JPH10158290A (en) 1996-11-25 1996-11-25 Retional glycoside and cosmetic obtained by formulating the same glycoside

Publications (1)

Publication Number Publication Date
JPH10158290A true JPH10158290A (en) 1998-06-16

Family

ID=18217651

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8329103A Pending JPH10158290A (en) 1996-11-25 1996-11-25 Retional glycoside and cosmetic obtained by formulating the same glycoside

Country Status (1)

Country Link
JP (1) JPH10158290A (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000058325A1 (en) * 1999-03-31 2000-10-05 Pierre Fabre Dermo-Cosmetique Bioprecursors of a retinoic derivative and pharmaceutical and/or cosmetic compositions
JP2002080338A (en) * 2000-06-20 2002-03-19 Shiseido Co Ltd Antiaging skin care preparation
JP2002187838A (en) * 2000-12-19 2002-07-05 Yakult Honsha Co Ltd Skin care preparation
JP2003183164A (en) * 2001-11-09 2003-07-03 Avon Products Inc Cosmetic therapeutic drug using novel retinoid
WO2005032501A1 (en) * 2003-09-08 2005-04-14 Beiersdorf Ag Agents for use on skin and/or hair containing quadruply substituted cyclohexene compounds
WO2005102252A3 (en) * 2004-04-26 2006-02-09 Beiersdorf Ag Skin and/or hair products, containing compounds with an isoprenoid structure
JP2006193427A (en) * 2005-01-11 2006-07-27 Nikko Chemical Co Ltd Hydrogenated retinoids or hydrogenated retinoid derivative and utilization thereof
WO2021176707A1 (en) 2020-03-06 2021-09-10 ビーエイチエヌ株式会社 Oral composition for inhibiting elastase and use thereof, elastase inhibitor, and method for inhibiting elastase activity by oral intake of elastase inhibitor

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000058325A1 (en) * 1999-03-31 2000-10-05 Pierre Fabre Dermo-Cosmetique Bioprecursors of a retinoic derivative and pharmaceutical and/or cosmetic compositions
FR2791679A1 (en) * 1999-03-31 2000-10-06 Fabre Pierre Dermo Cosmetique BIOPRECURSORS CAPABLE OF RELEASING A RETINOIC DERIVATIVE BY TAKING ADVANTAGE OF THE ENZYMATIC ACTIVITY OF THE SKIN SURFACE AND PHARMACEUTICAL AND / OR COSMETIC COMPOSITIONS
JP2002080338A (en) * 2000-06-20 2002-03-19 Shiseido Co Ltd Antiaging skin care preparation
JP2002187838A (en) * 2000-12-19 2002-07-05 Yakult Honsha Co Ltd Skin care preparation
JP4612180B2 (en) * 2000-12-19 2011-01-12 株式会社ヤクルト本社 Skin preparation
JP2003183164A (en) * 2001-11-09 2003-07-03 Avon Products Inc Cosmetic therapeutic drug using novel retinoid
WO2005032501A1 (en) * 2003-09-08 2005-04-14 Beiersdorf Ag Agents for use on skin and/or hair containing quadruply substituted cyclohexene compounds
WO2005102252A3 (en) * 2004-04-26 2006-02-09 Beiersdorf Ag Skin and/or hair products, containing compounds with an isoprenoid structure
JP2006193427A (en) * 2005-01-11 2006-07-27 Nikko Chemical Co Ltd Hydrogenated retinoids or hydrogenated retinoid derivative and utilization thereof
JP4548831B2 (en) * 2005-01-11 2010-09-22 日光ケミカルズ株式会社 Hydrogenated retinoid or hydrogenated retinoid derivative and use thereof
WO2021176707A1 (en) 2020-03-06 2021-09-10 ビーエイチエヌ株式会社 Oral composition for inhibiting elastase and use thereof, elastase inhibitor, and method for inhibiting elastase activity by oral intake of elastase inhibitor

Similar Documents

Publication Publication Date Title
KR101217382B1 (en) EXTERNAL DERMATOLOGICAL FORMULATION COMPRISING SACCHARIDE DERIVATIVE OF α,α-TREHALOSE
DE60027455T2 (en) OLIGOSACCHARIDEALDONIC ACID AND ITS TOPICAL ADMINISTRATION
US6495147B1 (en) Uses of D-xylose, the esters thereof and oligosaccharides containing xylose for improving the functionality of epidermal cells
US6468564B1 (en) Topical compositions containing lotus for skin treatment
US5885593A (en) Skin care composition including cyclodextrin materials and method for treating skin therewith
JPH111423A (en) Skin beautifying cosmetic
JP2008013564A (en) Use of at least one c-glycoside derivative as sedative
CN104736136A (en) Cosmetic or pharmaceutical moisturising ingredient
JPH0446112A (en) Trichogen
JP3923226B2 (en) Topical skin preparation
US20090197819A1 (en) Compositions for improving and repairing skin
JP2000051676A (en) Emulsifier and emulsion composition
JPH07277939A (en) Skin external preparation
JPH08283139A (en) Dermal preparation for external use
JPH10158290A (en) Retional glycoside and cosmetic obtained by formulating the same glycoside
JP2004091376A (en) Epidermis keratinization normalizing agent and skin care preparation for external use for skin containing the same
CN112773761B (en) Cosmetic composition, essence and preparation method thereof
US20040043047A1 (en) Cosmetic or dermatological compositions containing at least one substance for increasing the functionality and/or expression of the CD44 membrane receptors of skin cells
WO2017100873A1 (en) Cosmetic composition and use thereof
JP2008195629A (en) Photoaging amelioration agent for skin
JP2006249077A (en) External preparation for skin containing phosphorylated sugar
JP3507635B2 (en) Composition suitable for external use
JP2010037251A (en) Skin external preparation
JP2002516836A (en) Use of sophorolipids containing diacetylated lactones as stimulants of skin fibroblast metabolism
JP4004426B2 (en) Skin activation external composition